VEGFA and metastatic malignant neoplasm in the lymph nodes: were included in the multivariate logistic regression analysis, and the results (Table 3) showed that lymph node metastasis, Ccr of ≤60 mL per minute, RBC count of ≤3.3×1012 per liter, and combined therapy with vascular endothelial growth factor inhibitors (VEGFis) were risk factors influencing the occurrence of SHAEs (P<.05).